// App-Quantinova.ai

S201 : CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

Researchers

Presenter

  • Carmelo Carlo-Stella

Principal Investigators

  • Pier Luigi Zinzani

  • John Radford

  • Kami Maddocks

  • Antonio Pinto

  • Graham P. Collins

  • Veronika Bachanova

  • Nancy Bartlett

  • Isabelle Bence-Bruckler

  • Mehdi Hamadani

  • Justin Kline

  • Jiri Mayer

  • Kerry J. Savage

  • Ranjana Advani

  • Paolo Caimi

  • Ren-Olivier Casasnovas

  • Tatyana Feldman

  • Brian Hess

  • Mariana Bastos-Oreiro

  • Sunil Iyengar

  • Sandy Eisen

  • Yanina Negievich

  • Luqiang Wang

  • Jens Wuerthner

  • Alex F. Herrera

Medical Centers

  • Divis

  • Medical College of Wisconsin,BMT &amp

  • Oxford Cancer and Haematology Centre,NIHR Oxford Biomedical Research Centre, Churchill Hospital,Oxford,Vereinigtes Königreich

  • Royal Marsden Hospital, London,

  • Department of Medicine, University of Cambridge

  • Department of Hematology,

  • Cellular Therapy Program, Department of Medicine,Milwaukee,États-unis

  • The John Theurer Cancer Center at Hackensack Meridian Health,Hackensack,United States

  • Fondazione G. Pascale, IRCCS,Istituto Nazionale Tu

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • Division of Nephrology, Ohio State University Medical Center, Columbus, OH

  • The John Theurer Cancer Center at Hackensack Meridian Health,Hackensack,United States

  • Haematology Department,Gregorio Marañón Health Research Institute, Hospital General Universitario Gregorio Marañón,Madrid,Espagne

  • Department of Hematology and Hematopoietic Cell Transplantation,City of Hope Comprehensive Cancer Center,Duarte,Stati Uniti

  • Internal Medicine,University Hospital and Masaryk University,Brno,Tschechische Republik

  • Hematology,Institute of Hematology Seràgnoli University of Bologna,Bologna,Italy

  • Division of Nephrology, Ohio State University Medical Center, Columbus, OH

  • Oxford Cancer and Haematology Centre,NIHR Ox

  • Department of Hematology,University Hospital F. Mitterrand and Inserm UMR 1231,Dijon,Frankreich

  • Hematology,Institute of Hematology Seràgnoli University of Bologna,Bologna,Italy

  • Ottawa-Hospital General Campus,The Ottawa Hospital-General Campus,Ottawa,Canada

  • Royal Marsden Hospital,Sutton,Regno Unito

  • Division of Hematology and Medical Oncology, Department of Medicine,Medical University of South Carolina,Charleston,États-unis

  • Fondazione G. Pascale Istituto Nazionale Tumori, Naples, Italy

  • ADC Therapeutics America, Inc, Murray Hill

  • Cellular Therapy Program, Department of Medicine,Milwaukee,États-unis

  • Department of Hematology and Hematopoietic Cell Transplantation,City of Hope Comprehensive Cancer Center,Duarte,Stati Uniti

  • Haematology Department,Gregorio Marañón Health Research Institute, Hospital General Universitario Gregorio Marañón,Madrid,Espagne

  • Hematology,Institute of Hematology Seràgnoli University of Bologna,Bologna,Italy

  • Department of Medical Oncology,BC Cancer and University of British Columbia,Vancouver,Kanada

  • Cancer Center,Cleveland Clinic/Case Comprehensive Cancer Center,Cleveland,Stati Uniti

  • Division of Nephrology, Ohio State University Medical Center, Columbus, OH

  • Division

  • Department of Medical Oncology,BC Cancer and University of British Columbia,Vancouver,Kanada

  • Division of Oncology, Department of Medicine,Stanford University,Stanford,Vereinigte Staaten

  • Hematopoietic Cell Transplantation,C

  • ADC Therapeutics SA,Epalinges,Schweiz

  • ADC Therapeutics SA,Epalinges,Schweiz

  • Ottawa-Hospital General Campus,The Ottawa Hospital-General Campus,Ottawa,Canada

  • Department of Hematology,University Hospital F. Mitterrand and Inserm UMR 1231,Dijon,Frankreich

  • Department of Oncology and Hematology,Humanitas Clinical and Research Center - IRCCS and Humanitas University,Rozzano, Milano,Italy

  • ADC Therapeutics America, Inc, Murray Hill

  • Cellular Therapy Program, Department of Medicine,Milwaukee,États-unis

  • Division of Hematology and Medical Oncology, Department of Medicine,Medical University of South Carolina,Charleston,États-unis

  • ADC Therapeutics America, Inc, Murray Hill

  • John Theurer Cancer Center,Hackensack Meridian Health,Hackensack,Estados Unidos

  • Division of Oncology, Department of Medicine,Stanford University,Stanford,Vereinigte Staaten

  • ADC Therapeutics SA,Epalinges,Швейцария

  • Department of Medicine,The University of Chicago,Chicago,Estados Unidos

  • Internal Medicine,University Hospital and Masaryk University,Brno,Tschechische Republik

  • Hematology,Institute of Hematology Seràgnoli University of Bologna,Bologna,Italien

  • ADC Therapeutics America, Inc, Murray Hill

  • The John Theurer Cancer Center at Hackensack Meridian Health,Hackensack,United States

  • Division of Nephrology, Ohio State University Medical Center, Columbus, OH

  • Cancer Center,Cleveland Clinic/Case Comprehensiv

  • Hematology

  • ADC Therapeutics SA,Epalinges,Schweiz

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • ADC Therapeutics SA,Epalinges,Schweiz

  • Division of Oncology,Washington University School of Medicine in St. Louis,St. Louis,United States

  • Department of Medicine, University of Chicago, Chicago

  • Department of Medicine, University of Chicago, Chicago

  • Haematology &amp

  • Internal Medicine,University Hospital and Masaryk University,Brno,Tschechische Republik

  • NIHR Clinical Research Facility, the Christie NHS Foundation Trust and University of Manchester, Manchester Academic Health Science Centre,Manchester,Vereinigtes Königreich

  • Cancer Center,Cleveland Clinic/Case Comprehensive Cancer Center,Cleveland,Stati Uniti

  • Division of Oncology,Washington University School of Medicine in St. Louis,St. Louis,United States

  • Department of Medical Oncology

  • Division of Medical Oncology, Department of Internal...

  • Oxford Cancer and Haematology Centre,NIHR Oxford Biomedical Research Centre, Churchill Hospital,Oxford,Vereinigtes Königreich

  • NIHR Clinical Research Facility, the Christie NHS Foundation Trust and University

  • Cellular

  • NIHR Clinical Research Facility, the Christie NHS Foundation Trust and University of Manchester, Manchester Academic Health Science Centre,Manchester,Vereinigtes Königreich

  • Oxford Cancer and Haematology Centre,NIHR Oxford Biomedical Research Centre, Churchill Hospital,Oxford,Vereinigtes Königreich

  • ADC Therapeutics America, Inc, Murray Hill

  • Division of Oncology, Department of Medicine,Stanford University,Stanford,Vereinigte Staaten

  • Hematology,Institute of Hematology Seràgnoli University of Bologna,Bologna,Italien

  • Fondazione G. Pascale Istituto Nazionale Tumori, Naples, Italy

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • Cancer Center,Cleveland Clinic/Case Comprehensive Cancer Center,Cleveland,Stati Uniti

  • Department of Hematology,University Hospital F. Mitterrand and Inserm UMR 1231,Dijon,Frankreich

  • Department of Oncology and Hematology,Humanitas Clinical and Research Center - IRCCS and Humanitas University,Rozzano, Milano,Italy

  • The Royal Marsden Hospital, London, United Kingdom

  • Division of Oncology,Washington University School of Medicine in St. Louis,St. Louis,United States

  • Division of Hematology and Medical Oncology, Department of Medicine,Medical University of South Carolina,Charleston,États-unis

  • Fondazione G. Pascale Istituto Nazionale Tumori, Naples, Italy

  • Department of Oncology and Hematology,Humanitas Clinical and Research Center - IRCCS and Humanitas University,Rozzano, Milano,Italy

  • Department of Hematology,

  • Royal Marsden Hospital,London,Соединённое Королевство

  • Internal Medicine,University Hospital and Masaryk University,Brno,Tschechische Republik

  • Royal Marsden Hospital,Sutton,Regno Unito

  • Fondazione G. Pascale Istituto Nazionale Tumori, Naples, Italy

  • Haematology Department,Gregorio Marañón Health Research Institute, Hospital General Universitario Gregorio Marañón,Madrid,Espagne

  • ADC

  • Division of Oncology, Department of Medicine,Stanford University,Stanford,Vereinigte Staaten

  • ADC Therapeutics SA,Epalinges,Schweiz

  • Cancer Center,Cleveland Clinic/Case Comprehensive Cancer Center,Cleveland,Stati Uniti

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • Division of Nephrology, Ohio State University Medical Center, Columbus, OH

  • Department of Medicine,The University of Chicago,Chicago,United States

  • ADC Therapeutics SA,Epalinges,Schweiz

  • Haematologiy,Royal Free Hospital,London,Royaume-uni

  • Division of Oncology,Washington University School of Medicine in St. Louis,St. Louis,United States

  • Ottawa-Hospital General Campus,The Ottawa Hospital-General Campus,Ottawa,Canada

  • Internal Medicine,University Hospital and Masaryk University,Brno,Tschechische Republik

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • John

  • Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

  • ADC Therapeutics SA,Epalinges,Schweiz

  • ADC Therapeutics America, Inc, Murray Hill

Locations

  • Italy

  • United States

  • Canada

  • Czech Republic

  • France

  • India

  • Puerto Rico

  • Spain

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • Hematocrit

Drug/Treatment

  • ADCT301

  • Adcetris

Outcome

  • N/A

Study Design

  • Open Label

  • Multicenteric

Phase

  • II

Study Id's

  • NCT04052997

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved